BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 6, 2017
View Archived Issues
Lakewood-Amedex advancing second bisphosphocin candidate
Read More
Sentien Biotechnologies closes series A financing to fund development of SBI-101
Read More
FDA grants orphan drug designation to valproic acid for DLBCL
Read More
ProMetic Life Sciences completes plasminogen BLA filing
Read More
ConverGene enters CRADA with NINDS
Read More
Promising preclinical data for novel first-in-class pan-FGFR antibody, MM-161
Read More
Finch Therapeutics, Takeda to jointly develop FIN-524 for IBD
Read More
Pivotal ZEUS trial of Zolyd in cUTI meets primary endpoint
Read More
Allergan reports data from proof-of-concept phase II trial of Botox in major depressive disorder
Read More
Ligand and Marinus enter new agreement for Captisol-enabled ganaxolone
Read More
Charles River Laboratories and Nimbus Therapeutics enter strategic partnership
Read More
FUJIFILM presents novel irreversible and potent FLT3 inhibitor for AML treatment
Read More
Battelle and Nanotherapeutics form alliance on medical countermeasures
Read More
Enumeral Biomedical enters MoU with ICAV to pursue infectious disease collaboration
Read More
Takeda enrolls more than 20,000 children and adolescents in phase III dengue vaccine trial
Read More
R-IMPP, a new small molecule anti-secretagogue of PCSK9 with a new mechanism of action
Read More
Galapagos doses first patient in EQUATOR study of filgotinib
Read More
Corbus Pharmaceuticals to begin phase III study of anabasum in systemic sclerosis
Read More
First-in-human results for GSK-2881078 in the treatment of muscle wasting
Read More
Marina Biotech provides corporate update
Read More
Suven Life Sciences presents muscarinic acetylcholine M1 receptor PAMs
Read More
Calitor Sciences patents JAK, FLT3 and ARK kinase inhibitors
Read More
Merck KGaA divulges IRAK inhibitors
Read More
Ohio State University and collaborator identify estrogen receptor beta agonists
Read More
Metacrine discovers farnesoid X-activated receptor agonists
Read More